A61K 9/0075
For inhalation via a dry powder inhaler [dpi]
Official title: {for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles}
A61K9/0075 (For inhalation via a dry powder inhaler [dpi]) appears on 1,345 US grants and 2,577 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,345
- Published applications
- 2,577
- Assignees
- 764
- Inventors
- 3,086
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 7 | 0 |
| 1997 | 13 | 0 |
| 1998 | 14 | 0 |
| 1999 | 27 | 0 |
| 2000 | 30 | 0 |
| 2001 | 24 | 23 |
| 2002 | 35 | 73 |
| 2003 | 46 | 128 |
| 2004 | 29 | 111 |
| 2005 | 26 | 116 |
| 2006 | 31 | 83 |
| 2007 | 28 | 85 |
| 2008 | 28 | 77 |
| 2009 | 20 | 94 |
| 2010 | 29 | 86 |
| 2011 | 34 | 80 |
| 2012 | 57 | 106 |
| 2013 | 55 | 76 |
| 2014 | 69 | 101 |
| 2015 | 51 | 134 |
| 2016 | 59 | 122 |
| 2017 | 70 | 121 |
| 2018 | 69 | 89 |
| 2019 | 66 | 102 |
| 2020 | 73 | 132 |
| 2021 | 66 | 131 |
| 2022 | 59 | 110 |
| 2023 | 55 | 116 |
| 2024 | 53 | 102 |
| 2025 | 57 | 101 |
| 2026 | 33 | 78 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Powder formulations for inhalation6 Oct 2026US 12,751,916 B2Christian-Albrechts-Universität zu Kiel
- Methods for delivery of psychedelic medications by inhalation and systems for performing the methods6 Oct 2026US 12,751,940 B2Cybin IRL Limited
- Treatment for interstitial lung disease22 Sep 2026US 12,740,954 B2United Therapeutics Corporation
- Treatment for interstitial lung disease15 Sep 2026US 12,734,143 B2United Therapeutics Corporation
- Crystalline forms of N-{3-[(1S)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2-yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methods11 Aug 2026US 12,703,693 B2GB002, Inc.
- Dry powder formulations of epinephrine and associated methods1 Oct 2026US 2026/0294803 A1Belhaven BioPharma Inc.
- Dry powder formulations of epinephrine and associated methods1 Oct 2026US 2026/0294804 A1Belhaven BioPharma Inc.
- Broad-spectrum antibiotic hybrids for the treatment of multi-drug resistant infections1 Oct 2026US 2026/0295059 A1Monash University
- Compositions, devices, and methods for intranasal delivery of dry powder epinephrine1 Oct 2026US 2026/0295182 A1Belhaven BioPharma Inc.
- Pharmaceutical dry powder composition and methods for treating respiratory tract infections24 Sep 2026US 2026/0283946 A1
Most cited
By later US patents
- Particles incorporating surfactants for pulmonary drug delivery537US 5,855,913 AMassachusetts Instite of Technology · 1999
- Aerodynamically light particles for pulmonary drug delivery468US 5,874,064 AMassachusetts Institute of Technology · 1999
- Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use358US 6,703,047 B2Incept, LLC · 2004
- Dispersible antibody compositions and methods for their preparation and use351US 6,019,968 AInhale Therapeutic Systems · 2000
- Systemic administration of a therapeutic preparation259US 5,506,203 AAstra AB · 1996